Efficacy of suicide gene therapy in hypoxic rat 9L glioma cells

Journal of Neuro-Oncology

Volumn 90, Issue 1, 2008, Pages 19-24

  Kumar, S ^a   Brown, S L ^a   Kolozsvary, A ^a   Freytag, S O ^a   Kim, J H ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Cytosine deaminase; Hypoxia; Pimonidazole; Suicide gene therapy; Thymidine kinase

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; HYBRID PROTEIN; PIMONIDAZOLE; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CELL HYPOXIA; CELL KILLING; CELL METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; EXPERIMENTAL NEOPLASM; GLIOMA; GLIOMA CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; RAT; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BRAIN NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CYTOSINE DEAMINASE; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GLIOMA; MALE; MICE; RATS; THYMIDINE KINASE;

EID: 50649087480     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9635-0     Document Type: Article

References (25)

1. Freytag SO, Stricker H, Peabody J et al (2007) Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer. Mol Ther 15:636-642
2. Barzon L, Zanusso M, Colombo F et al (2006) Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther 13:539-554
3. Kim JH, Kolozsvary A, Rogulski K et al (1998) Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Cancer J Sci Am 4:364-369
4. Rogulski KR, Zhang K, Kolozsvary A et al (1997) Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin Cancer Res 3:2081-2088
5. Evans SM, Judy KD, Dunphy I et al (2004) Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10:8177-8184
6. Bernsen HJ, Rijken PF, Peters H et al (1991) Hypoxia in a human intracerebral glioma model. J Neurosurg 93:449-454
7. Chen JK, Hu LJ, Wang D et al (2007) Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro. Int J Radiat Oncol Biol Phys 67:1538-1547
8. Rogulski KR, Kim JH, Kim SH et al (1997) Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther 8:73-85
9. Kim JH, Kim SH, Brown SL et al (1994) Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res 54:6053-6056
10. Raleigh JA, Chou SC, Arteel GE et al (1999) Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151:580-589
11. Bussink J, Kaanders JH, van der Kogel AJ (2003) Tumor hypoxia at the micro-regional level: Clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 67:3-15
12. Takahashi M, Yasui H, Ogura A et al (2008) X irradiation combined with TNF alpha-related apoptosis-inducing ligand (TRAIL) reduces hypoxic regions of human gastric adenocarcinoma xenografts in SCID mice. J Radiat Res 49:153-161
13. Selvakumaran M, Yao KS, Feldman MD et al (2008) Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis. Biochem Pharmacol 75:627-638
14. Jankovic B, Aquino-Parsons C, Raleigh JA et al (2006) Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Clin Cytom 70B:45-55
15. Sersa G, Jarm T, Kotnik T et al (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98:388-398
16. Gray LH, Conger AD, Ebert M et al (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26:638-648
17. Thomlinson RH, Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9:539-549
18. Gabalski EC, Adam M, Pinto H et al (1998) Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers. Laryngoscope 108:1856-1860
19. Fox ME, Lemmon MJ, Mauchline ML et al (1996) Anaerobic bacteria as a delivery system for cancer gene therapy: In vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther 3:173-178
20. Brown JM (2002) Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1:453-458
21. Lee CH, Wu CL, Shiau AL (2007) Hypoxia-induced cytosine deaminase gene expression for cancer therapy. Hum Gene Ther 18:27-38
22. Koshikawa N, Takenaga K, Tagawa M et al (2000) Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells. Cancer Res 60:2936-2941
23. Greco O, Marples B, Joiner MC (2003) How to overcome (and exploit) tumor hypoxia for targeted gene therapy. J Cell Physiol 197:312-325
24. Jain RK (1994) Barriers to drug delivery in solid tumors. Sci Am 271:58-65
25. Freytag SO, Stricker H, Pegg J et al (2003) Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res 63:7497-7506